Outcomes are still associated to operator experience and institutional volume

This study is a retrospective analysis of 2,243,209 PCI stenting procedures in the USA between 2005 and 2009. During this period, a reduction in the number of PCI procedures was observed (also observed globally) from 53 in previous years to 33 procedures per operator per year, and from 1,024 to 693 per hospital per year.

 

Primary end point was in-hospital mortality and secondary end point was a composite of in-hospital mortality and peri-procedural complications.

 

Overall in-hospital mortality was 1.08% and peri-procedural complications rate was 7.10%, most common being vascular complications (2.01%), followed by cardiac complications (1.76%), respiratory failure (1.50%) and postoperative stroke (0.99%).

 

After adjustment for potential confounders, it was observed that In-hospital mortality and peri-procedural complications both increased significantly as PCI volume at operator level declined.

 

The chance of death or complications doubles among those operators with ≤15 PCIs a year, compared to those with >100 PCIs a year (10.1% vs 5.1% respectively; p<0.001). Operator volume also reduces in-hospital stay and associated costs.

 

Initially, a similar relationship was observed between outcomes and institutional volume; however, after adjusting by operator volume, the observed difference was considered non-significant.

 

Conclusion

In-hospital mortality rate in the context of PCI is low. The higher the number of procedures by operator, the lower mortality, complications, in-hospital stay and costs. 

 

Editorial Comment

Is there a magic number that will turn operators into experts? The last 2013 ACCF/AHA/SCAI issue recommended at least 50 PCIs a year per operator and 200 per center, and this is an amendment to the previous document that had recommended 75 per operator, a reasonable change given the decreasing number of procedures.

 

The study showed that an important number of operators did not reach the 50 annual procedures, which could be a problem for future PCIs, if this global decreasing tendency continues in the context of a clear relationship between outcomes and volume.

 

Original title: Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009). 

Reference: Badheka AO et al. Circulation. 2014; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...